Sign In
Buy CRL
$229.75
-3.66 (-1.57%)
At Close: Jul 13, 2026
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company,
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with Arovella Therapeutics Ltd (ASX: ALA), a biotechnology
Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able
11:33am, Tuesday, 07'th Jul 2026
The last months were eventful for Achieve Life Sciences, sending the stock strongly down, but later to a new high for the year, implying optimism about the future path. Achieve is, in my view, a more
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
12:25pm, Friday, 03'rd Jul 2026
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible
LH or CRL: Which Is the Better Value Stock Right Now?
12:40pm, Wednesday, 01'st Jul 2026
Investors with an interest in Medical Services stocks have likely encountered both Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two companies is the best option for t
Is This the Right Time to Hold CRL Stock in Your Portfolio?
10:30am, Wednesday, 01'st Jul 2026
Charles River Laboratories International, Inc. CRL is well-poised to grow in the coming quarters owing to the strength of its Research Models and Services (“RMS”) business and broader CRADL adopt
Achieve Life Sciences: CRL Is Fixable, So I Remain Bullish
07:30am, Tuesday, 23'rd Jun 2026
Achieve Life Sciences remains a cytisinicline story, with very positive smoking-cessation data. This also gives cytisinicline some added optionality for vaping. The FDA's CRL appears to be mostly abou
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
05:44pm, Monday, 22'nd Jun 2026
Bio-Rad Laboratories offers high profitability and a liquid balance sheet with a current ratio above 5x. Charles River Laboratories International maintains a leading scale in drug discovery services w
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
08:00am, Thursday, 18'th Jun 2026
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly TuneLab, a collaborative AI/ML drug discovery pl
The Healthcare M&A Wave
12:30pm, Wednesday, 17'th Jun 2026
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
Disc Medicine: The CRL Has Created A Cleaner Bull Case
10:38am, Wednesday, 17'th Jun 2026
Disc Medicine (IRON) offers a differentiated hematology platform with late-stage assets, robust cash reserves, and a clear regulatory path for bitopertin. APOLLO Phase 3 trial for bitopertin in EPP/XL
Futures are trading mixed as we hit the midweek point, as the Space Exploration Technologies (NASDAQ: SPCX) or SpaceX IPO rush is starting to fade somewhat.
LH vs. CRL: Which Stock Is the Better Value Option?
12:41pm, Monday, 15'th Jun 2026
Investors looking for stocks in the Medical Services sector might want to consider either Labcorp Holdings (LH) or Charles River Laboratories (CRL). But which of these two stocks offers value investor
Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
12:12pm, Wednesday, 03'rd Jun 2026
Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Charles River Associates (CRA) to Present at the Sidoti Small-Cap Virtual Conference
08:30am, Wednesday, 03'rd Jun 2026
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the Company will partici
